Denmark Blood-based Biomaker For Sports Medicine Market Size & Outlook
Denmark blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Denmark blood-based biomaker for sports medicine market highlights
- The Denmark blood-based biomaker for sports medicine market generated a revenue of USD 7.6 million in 2023 and is expected to reach USD 11.4 million by 2030.
- The Denmark market is expected to grow at a CAGR of 6% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 7.6 million |
| Market revenue in 2030 | USD 11.4 million |
| Growth rate | 6% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Denmark accounted for 1.1% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 18.42% in 2023. Horizon Databook has segmented the Denmark blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In response to the growing need for effective injury management, the market for blood-based biomarkers in sports medicine in Denmark is expected to witness growth over the coming decade. These biomarkers are crucial for detecting, monitoring, and preventing sports-related injuries. According to Kiropraktik i Centrum, it is estimated that over 700,000 individuals in Denmark experience a sports injury annually.
As sports participation and physical activity levels continue to rise, the incidence of such injuries is expected to increase. Overuse injuries, including Achilles tendonitis, shoulder impingement, and a runner’s knee, are common among athletes. These injuries are particularly prevalent in endurance sports, such as running, cycling, and swimming.
In Denmark, sports insurance is critical in managing the financial aspects of sports injuries and providing coverage for medical treatments and rehabilitation. As sports participation grows, the need for effective injury prevention and management is expected to rise, which is increasingly supported by advancements in sports medicine.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Denmark blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Denmark Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
